These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 29937163

  • 1. Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes.
    Linxweiler J, Saar M, Al-Kailani Z, Janssen M, Ezziddin S, Stöckle M, Siemer S, Ohlmann CH.
    Surg Oncol; 2018 Jun; 27(2):138-145. PubMed ID: 29937163
    [Abstract] [Full Text] [Related]

  • 2. Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series.
    Bravi CA, Fossati N, Gandaglia G, Suardi N, Mazzone E, Robesti D, Osmonov D, Juenemann KP, Boeri L, Jeffrey Karnes R, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A.
    Eur Urol; 2020 Dec; 78(6):779-782. PubMed ID: 32624281
    [Abstract] [Full Text] [Related]

  • 3. Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management.
    Linxweiler J, Sprenk J, Cascetta K, Pryalukhin A, Hölters S, Zeuschner P, Nini A, Al-Kailani Z, Ezziddin S, Bohle RM, Fries P, Ohlmann CH, Heinzelbecker J, Siemer S, Stöckle M, Junker K, Saar M.
    J Urol; 2021 Jul; 206(1):88-96. PubMed ID: 33617326
    [Abstract] [Full Text] [Related]

  • 4. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought.
    Bravi CA, Fossati N, Gandaglia G, Suardi N, Mazzone E, Robesti D, Osmonov D, Juenemann KP, Boeri L, Jeffrey Karnes R, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A.
    Eur Urol; 2020 Nov; 78(5):661-669. PubMed ID: 32624288
    [Abstract] [Full Text] [Related]

  • 5. Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.
    Winter A, Henke RP, Wawroschek F.
    BMC Urol; 2015 Feb 21; 15(1):10. PubMed ID: 25881245
    [Abstract] [Full Text] [Related]

  • 6. Oncological outcome of patients treated with spot-specific salvage lymphnode dissection (sLND) for positron-emission tomography (PET)-positive prostate cancer (PCa) relapse.
    Hiester A, Nini A, Niegisch G, Arsov C, Hautzel H, Antke C, Schimmöller L, Albers P, Rabenalt R.
    World J Urol; 2019 Oct 21; 37(10):2081-2090. PubMed ID: 30643974
    [Abstract] [Full Text] [Related]

  • 7. The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.
    Porres D, Pfister D, Thissen A, Kuru TH, Zugor V, Buettner R, Knuechel R, Verburg FA, Heidenreich A.
    Prostate Cancer Prostatic Dis; 2017 Mar 21; 20(1):85-92. PubMed ID: 27824042
    [Abstract] [Full Text] [Related]

  • 8. PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis.
    Schmidt-Hegemann NS, Buchner A, Eze C, Rogowski P, Schaefer C, Ilhan H, Li M, Fendler WP, Bartenstein P, Ganswindt U, Stief C, Belka C, Kretschmer A.
    Strahlenther Onkol; 2020 Jul 21; 196(7):637-646. PubMed ID: 32211942
    [Abstract] [Full Text] [Related]

  • 9. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.
    Rigatti P, Suardi N, Briganti A, Da Pozzo LF, Tutolo M, Villa L, Gallina A, Capitanio U, Abdollah F, Scattoni V, Colombo R, Freschi M, Picchio M, Messa C, Guazzoni G, Montorsi F.
    Eur Urol; 2011 Nov 21; 60(5):935-43. PubMed ID: 21840116
    [Abstract] [Full Text] [Related]

  • 10. Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy.
    Oderda M, Joniau S, Palazzetti A, Falcone M, Melloni G, Van Den Bossche H, Deconinck S, Zattoni F, Karnes RJ, Gontero P.
    Eur Urol Focus; 2018 Mar 21; 4(2):288-293. PubMed ID: 30205893
    [Abstract] [Full Text] [Related]

  • 11. Initial multicentre experience of 68 gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited.
    Siriwardana A, Thompson J, van Leeuwen PJ, Doig S, Kalsbeek A, Emmett L, Delprado W, Wong D, Samaratunga H, Haynes AM, Coughlin G, Stricker P.
    BJU Int; 2017 Nov 21; 120(5):673-681. PubMed ID: 28548372
    [Abstract] [Full Text] [Related]

  • 12. Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.
    Fossati N, Suardi N, Gandaglia G, Bravi CA, Soligo M, Karnes RJ, Shariat S, Battaglia A, Everaerts W, Joniau S, Van Poppel H, Rajarubendra N, Gill IS, Larcher A, Mottrie A, Schmautz M, Heidenreich A, Kalz A, Osmonov D, Juenemann KP, Herlemann A, Gratzke C, Stief C, Montorsi F, Briganti A.
    Eur Urol; 2019 Jan 21; 75(1):176-183. PubMed ID: 30301694
    [Abstract] [Full Text] [Related]

  • 13. Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.
    Abdollah F, Briganti A, Montorsi F, Stenzl A, Stief C, Tombal B, Van Poppel H, Touijer K.
    Eur Urol; 2015 May 21; 67(5):839-49. PubMed ID: 24698524
    [Abstract] [Full Text] [Related]

  • 14. Salvage lymph node dissection in hormone-naïve men: How effective is surgery?
    Hanske J, Ostholt J, Roghmann F, Müller G, Braun K, Gomez B, von Landenberg N, von Bodman C, Palisaar RJ, Liermann D, Noldus J, Brock M.
    Urol Oncol; 2019 Nov 21; 37(11):812.e17-812.e24. PubMed ID: 31327750
    [Abstract] [Full Text] [Related]

  • 15. Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
    Sivaraman A, Benfante N, Touijer K, Coleman J, Scardino P, Laudone V, Eastham J.
    Investig Clin Urol; 2018 Mar 21; 59(2):83-90. PubMed ID: 29520383
    [Abstract] [Full Text] [Related]

  • 16. Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients.
    Herlemann A, Kretschmer A, Buchner A, Karl A, Tritschler S, El-Malazi L, Fendler WP, Wenter V, Ilhan H, Bartenstein P, Stief CG, Gratzke C.
    Oncotarget; 2017 Oct 13; 8(48):84180-84192. PubMed ID: 29137414
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.
    Suardi N, Gandaglia G, Gallina A, Di Trapani E, Scattoni V, Vizziello D, Cucchiara V, Bertini R, Colombo R, Picchio M, Giovacchini G, Montorsi F, Briganti A.
    Eur Urol; 2015 Feb 13; 67(2):299-309. PubMed ID: 24571959
    [Abstract] [Full Text] [Related]

  • 18. 68Ga-PSMA ligand PET/CT integrating indocyanine green-guided salvage lymph node dissection for lymph node metastasis after radical prostatectomy.
    Li TC, Wang Y, Xiao CT, Li MZ, Liu XP, Huang WT, Li LY, Li K, Di JM, Wen XQ, Gao X.
    Asian J Androl; 2022 Feb 13; 24(1):97-101. PubMed ID: 34213490
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
    Falkenbach F, Knipper S, Koehler D, Ambrosini F, Steuber T, Graefen M, Budäus L, Eiber M, Lunger L, Lischewski F, Heck MM, Maurer T.
    World J Urol; 2023 Sep 13; 41(9):2343-2350. PubMed ID: 37515651
    [Abstract] [Full Text] [Related]

  • 20. Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy.
    Van Eecke H, Devos G, Vansevenant B, Vander Stichele A, Devlies W, Berghen C, Everaerts W, De Meerleer G, Joniau S.
    Int J Urol; 2023 Jan 13; 30(1):92-99. PubMed ID: 36305586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.